214 related articles for article (PubMed ID: 31017746)
1. Applying the Paris system for reporting urine cytology to challenging cytology cases.
Glass R; Rosca O; Raab S; Szabelska J; Chau K; Sheikh-Fayyaz S; Cocker R
Diagn Cytopathol; 2019 Jul; 47(7):675-681. PubMed ID: 31017746
[TBL] [Abstract][Full Text] [Related]
2. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
[TBL] [Abstract][Full Text] [Related]
3. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
4. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.
Danakas A; Sweeney M; Cheris S; Agrawal T
J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054
[TBL] [Abstract][Full Text] [Related]
5. The utility of upper urinary tract urine cytology before and after application of the Paris system.
Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
[TBL] [Abstract][Full Text] [Related]
6. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
7. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
[TBL] [Abstract][Full Text] [Related]
8. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
9. Targeted education as a method for reinforcing Paris System criteria and reducing urine cytology atypia rates.
Compton ML; Weiss VL; Barkan GA; Ely KA
J Am Soc Cytopathol; 2021; 10(1):9-13. PubMed ID: 32771394
[TBL] [Abstract][Full Text] [Related]
10. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
[TBL] [Abstract][Full Text] [Related]
11. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
[TBL] [Abstract][Full Text] [Related]
12. Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology.
Northrup V; Acar BC; Hossain M; Acker MR; Manuel E; Rahmeh T
Diagn Cytopathol; 2018 Dec; 46(12):1022-1030. PubMed ID: 30375194
[TBL] [Abstract][Full Text] [Related]
13. Two-year study on the application of the Paris system for urinary cytology in a cancer centre.
de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M
Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587
[TBL] [Abstract][Full Text] [Related]
14. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?
Richardson CJ; Pambuccian SE; Barkan GA
Cancer Cytopathol; 2020 Feb; 128(2):119-125. PubMed ID: 31774630
[TBL] [Abstract][Full Text] [Related]
15. Comparison of urine cytology diagnostic reports before and after the implementation of the Paris System classification system in China.
Ma C; Zhang L
Cytopathology; 2020 Sep; 31(5):457-462. PubMed ID: 32246545
[TBL] [Abstract][Full Text] [Related]
16. Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks.
Chan E; Balassanian R; Tabatabai ZL; Lou H; Vohra P
Cancer Cytopathol; 2018 Sep; 126(9):809-816. PubMed ID: 30203925
[TBL] [Abstract][Full Text] [Related]
17. Causes of false-negative for high-grade urothelial carcinoma in urine cytology.
Lee PJ; Owens CL; Lithgow MY; Jiang Z; Fischer AH
Diagn Cytopathol; 2016 Dec; 44(12):994-999. PubMed ID: 27781412
[TBL] [Abstract][Full Text] [Related]
18. The continual impact of the Paris System on urine cytology, a 3-year experience.
Stanzione N; Ahmed T; Fung PC; Cai D; Lu DY; Sumida LC; Moatamed NA
Cytopathology; 2020 Jan; 31(1):35-40. PubMed ID: 31596979
[TBL] [Abstract][Full Text] [Related]
19. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245
[TBL] [Abstract][Full Text] [Related]
20. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
